{{Rsnum
|rsid=600550
|Gene=MS4A4E
|Chromosome=11
|position=60230193
|Orientation=plus
|GMAF=0.3981
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=MS4A4E
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 44.2 | 43.4 | 12.4
| HCB | 32.8 | 51.8 | 15.3
| JPT | 38.1 | 47.8 | 14.2
| YRI | 26.5 | 53.1 | 20.4
| ASW | 31.6 | 49.1 | 19.3
| CHB | 32.8 | 51.8 | 15.3
| CHD | 35.8 | 44.0 | 20.2
| GIH | 55.4 | 39.6 | 5.0
| LWK | 43.6 | 45.5 | 10.9
| MEX | 39.7 | 41.4 | 19.0
| MKK | 44.2 | 42.9 | 12.8
| TSI | 52.9 | 34.3 | 12.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23118302
  |Trait=Lipoprotein-associated phospholipase A2 activity and mass
  |Title=Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.
  |RiskAllele=T
  |Pval=2E-11
  |OR=.01
  |ORtxt=[0.0068-0.0206] ng/ml decrease
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}